Ethics Unit, University Hospital of Lausanne, Lausanne, Switzerland.
Institute for Biomedical Ethics, University Medical Center, Geneva, Switzerland.
J Intensive Care Med. 2020 Aug;35(8):772-780. doi: 10.1177/0885066618784268. Epub 2018 Jun 21.
The whole-brain criterion of death provides that a person who has irreversibly lost all clinical functions of the brain is dead. Bedside brain death (BD) tests permit physicians to determine BD by showing that the whole-brain criterion of death has been fulfilled. In a nonsystematic literature review, we identified and analyzed case reports of a mismatch between the whole-brain criterion of death and bedside BD tests. We found examples of patients diagnosed as BD who showed (1) neurologic signs compatible with retained brain functions, (2) neurologic signs of uncertain origin, and (3) an inconsistency between standard BD tests and ancillary tests for BD. Two actions can resolve the mismatch between the whole-brain criterion of death and BD tests: (1) loosen the whole-brain criterion of death by requiring only the irreversible cessation of relevant brain functions and (2) tighten BD tests by requiring an ancillary test proving the cessation of intracranial blood flow. Because no one knows the precise brain functions whose loss is necessary to fulfill the whole-brain criterion of death, we advocate tightening BD tests by requiring the absence of intracranial blood flow.
全脑死亡标准规定,不可逆地失去大脑所有临床功能的人即为死亡。床边脑死亡 (BD) 测试可通过显示已满足全脑死亡标准来允许医生确定 BD。在非系统性文献回顾中,我们发现并分析了全脑死亡标准与床边 BD 测试之间不匹配的病例报告。我们找到了一些被诊断为 BD 的患者的例子,他们表现出 (1) 与保留的脑功能相容的神经学迹象,(2) 起源不确定的神经学迹象,以及 (3) 标准 BD 测试与 BD 的辅助测试之间的不一致。有两种方法可以解决全脑死亡标准与 BD 测试之间的不匹配:(1) 通过仅要求相关脑功能不可逆停止来放宽全脑死亡标准,以及 (2) 通过要求辅助测试证明颅内血流停止来收紧 BD 测试。由于没有人知道失去哪些精确的脑功能就足以满足全脑死亡标准,因此我们主张通过要求不存在颅内血流来收紧 BD 测试。